Unlike vaccines against viruses such as the flu or even COVID-19, melanoma vaccines don’t prevent the disease, Wu and her colleagues said.

Instead, they prevent the disease from returning in those considered at high risk for recurrence after surgery, they said. A custom-made vaccine against melanoma still protects against advanced disease four years after cancer patients receive it, according to a study published Thursday by Nature Medicine.